San Carlos, CA, United States of America

Hyojin Kim


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hyojin Kim: Innovator in Interleukin Production and Purification

Introduction

Hyojin Kim is a notable inventor based in San Carlos, California, recognized for his contributions to the field of biotechnology. He holds two patents that focus on innovative methods for interleukin production and purification, particularly involving cholix-IL-10 fusion proteins. His work aims to enhance therapeutic applications through advanced formulations.

Latest Patents

Hyojin Kim's latest patents include compositions and formulations that describe cholix-IL-10 fusion proteins. These proteins are characterized by their ability to elicit a distinct response in individuals when administered. This response may involve changes in levels of specific markers and the co-localization of IL-10 in the lamina propria. Additionally, his patents detail oral formulations of these fusion proteins, methods for purifying IL-10 delivery constructs, and configurations for site-specific release of therapeutic proteins in the small intestines or colon. The therapeutic proteins can exist in a dimer form, which is capable of crossing the gut epithelium, thereby enhancing their efficacy.

Career Highlights

Hyojin Kim is currently associated with Applied Molecular Transport Inc., where he continues to advance his research in the field of molecular transport and therapeutic delivery systems. His innovative approaches have the potential to significantly impact the treatment of various diseases through improved drug delivery mechanisms.

Collaborations

Hyojin collaborates with esteemed colleagues, including Derek Maclean and Randall J Mrsny, who contribute to the research and development efforts at Applied Molecular Transport Inc. Their combined expertise fosters a dynamic environment for innovation in biotechnology.

Conclusion

Hyojin Kim's work in interleukin production and purification exemplifies the cutting-edge advancements in biotechnology. His patents and ongoing research hold promise for the future of therapeutic applications, making significant strides in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…